Neuromodulation Partnerships

The University of Minnesota understands the challenges of translating an idea to a new therapy, medical device, or biotechnology.  Large or small, few companies meet all of their neuromodulation product development needs with in-house expertise and services. In addition, the University offers all the services of a Contract Research Organization  (CRO) with the benefits of convenience of our Twin Cities campuses, top-tier facilities, and world-class researchers and engineering domain experts. 


Technical Expertise:

  • Deep brain stimulation
  • Transcranial magnetic stimulation
  • Spinal cord stimulation
  • Autonomic neuromodulation
  • Targeted drug delivery
  • Functional ultrasound and magnetic resonance imaging
  • Transcranial direct stimulation


 The Partnership Process:

To connect our facilities, researchers, and services to your project needs, contact a liaison here

  1. Browse our site for resources in basic science, device development, preclinical studies, first in human, clinical trials, and initial release
  2. Contact the liaison whose expertise best matches your needs
  3. The liaison connects you to the right researchers, centers, programs, and resources for your unmet needs

    Profile: Greg Molnar

    source: NMRC webpageDr. Greg Molnar is a professor, inventor, and consultant in neuromodulation, who strives to strengthen University-industry partnerships. From his experience working in industry, Greg believes that industry partnerships with the University are essential to quickly and efficiently translate medical discoveries into commercial, meaningful neuromodulation therapies.

    Greg completed undergraduate and graduate work in neuroscience and neuromodulation, with particular  emphasis on the mechanism of action of deep brain stimulation to treat Parkinson’s disease. During these studies, Dr. Molnar started his own consulting company to innovate new therapy technologies. Upon graduation, he served for ten years as director of neuromodulation research at Medtronic, where he patented concepts that are benefiting patients today.

    Dr. Molnar was then recruited back to academia, to the department of neurology at the University of Minnesota. This role leverages his years of training in DBS and his knowledge of industry to advance the University’s new emphasis on industry partnerships. Alongside his ongoing DBS research, he seeks innovative ways to advance the University’s “Driven to Discover” slogan in ways that speed scientific discoveries to benefit the patient.